Juan Carlos Zúñiga-Pflücker

Prof. Juan Carlos Zúñiga-Pflücker

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2001 in Nature
Verified
Journal Article
Closed access
PDF file
NJNicholas Joza
Nicholas Joza
SSSantos A. Susin
Santos A. Susin
EDEric Daugas
Eric Daugas
WSWilliam L. Stanford
William L. Stanford
SCSarah K. Cho
Sarah K. Cho
JPJosef M Penninger
Josef M Penninger

1 December 2002 in Immunity
Verified
Journal Article
Closed access
TSThomas M. Schmitt
Thomas M. Schmitt
JZJuan Carlos Zúñiga-Pflücker
Juan Carlos Zúñiga-Pflücker

16 September 2007 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
TPTeresa Palomero
Teresa Palomero
MSMaria Luisa Sulis
Maria Luisa Sulis
MCMaria Cortina
Maria Cortina
PRPedro Jose Real
Pedro Jose Real
KBKelly Barnes
Kelly Barnes
AFAdolfo A Ferrando
Adolfo A Ferrando

4 July 2012 in Nature
Verified
Journal Article
Closed access
PDF file
MSMasato Sasaki
Masato Sasaki
CKChristiane B. Knobbe
Christiane B. Knobbe
JMJoshua C. Munger
Joshua C. Munger
ELEvan F. Lind
Evan F. Lind
DBDirk Brenner
Dirk Brenner
TMTak W. Mak
Tak W. Mak

25 February 1994 in Science
Verified
Journal Article
Closed access
PDF file
JCJeffrey M. Critchfield
Jeffrey M. Critchfield
MRMichael K. Racke
Michael K. Racke
JZJuan Carlos Zúñiga-Pflücker
Juan Carlos Zúñiga-Pflücker
BCBarbara Cannella
Barbara Cannella
CRCedric S. Raine
Cedric S. Raine
MLMichael J. Lenardo
Michael J. Lenardo
Encounters with antigen can stimulate T cells to become activated and proliferate, become nonresponsive to antigen, or to die. T cell death was shown to be a physiological response to interleukin-2-stimulated cell cycling and T cell receptor reengagement at high antigen doses. This feedback regulatory mechanism attenuates the immune response by deleting a portion of newly dividing, antigen-reactive T cells. This mechanism deleted autoreactive T cells and abrogated the clinical and pathological signs of autoimmune encephalomyelitis in mice after repetitive administration of myelin basic protein.